Heart Health
Bempedoic Acid Plus Ezetimibe Combo Targets LDL in Diabetic Patients
A Phase 2 trial tests whether a fixed-dose combination pill can safely lower LDL cholesterol in people with type 2 diabetes.
Clinical Trial
Jun 17, 2026 0
Results for "Bempedoic Acid"
20 articles
Brain Health
BACE Inhibitor Atabecestat Trial in Pre-Symptomatic Alzheimer's Risk Terminated Early
A phase 2/3 trial of the BACE inhibitor atabecestat in amyloid-positive asymptomatic adults was terminated before completion, raising questions about this drug class.
Clinical Trial
May 13, 2026 0
Brain Health
New Alzheimer's Drug BMS-984923 Completes Safety Testing in 51 Participants
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Clinical Trial
Mar 28, 2026 1
Brain Health
Alpha-Lipoic Acid Added to Flunarizine Tested for Teen Migraine Prevention
A completed Phase 4 trial from India evaluates whether ALA supplementation boosts flunarizine's migraine-prevention power in adolescents.
Clinical Trial
Jun 17, 2026 0
Brain Health
Retired Cholesterol Drug Shows Promise for Alzheimer's Prevention in Small Trial
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Clinical Trial
Mar 29, 2026 0
Brain Health
Drugs That Boost Brain Waste Clearance During Sleep Show Promise Against Alzheimer's
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
Clinical Trial
May 16, 2026 0
Brain Health
Repurposed Anti-Nausea Drug TEP Tested for Clearing Alzheimer's Brain Plaques
A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.
Clinical Trial
Jun 12, 2026 0
Heart Health
Chinese PCSK9 Inhibitor Trial Tests IBI306 for High-Risk Cholesterol Patients
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
Clinical Trial
Jun 7, 2026 0
Heart Health
Amiloride Shows Promise for Coronary Heart Disease Through Red Blood Cell Enhancement
Small trial explores how amiloride improves oxygen delivery to heart muscle by enhancing potassium transport in red blood cells.
Clinical Trial
Mar 28, 2026 4
Heart Health
Anacetrapib Added to Statins Tested for Cholesterol Control in Phase 3 Trial
Merck's CETP inhibitor anacetrapib was evaluated alongside statin therapy to assess LDL-C lowering and HDL-C raising in hypercholesterolemia patients.
Clinical Trial
Jun 15, 2026 0
Metabolic Health
EDP-305 Targets NASH in Phase 2 Trial Testing Two Doses Against Placebo
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Clinical Trial
Jun 18, 2026 0
Brain Health
Rapastinel Shows Lower Abuse Potential Than Ketamine in Phase 1 Trial
A completed Phase 1 trial compared the abuse liability of rapastinel versus ketamine in recreational polydrug users, with implications for safer depression treatment.
Clinical Trial
Jun 5, 2026 0
Heart Health
Phase 3 Trial Tests Obicetrapib for Hard-to-Treat High Cholesterol
A completed Phase 3 trial evaluates obicetrapib added to maximum lipid-lowering therapy in patients with familial hypercholesterolemia and ASCVD.
Clinical Trial
Jun 12, 2026 0
Supplements
Ginkgo Extract Shows Promise for Preventing Alzheimer's Progression in Major Trial
Large 7-year study tested whether Ginkgo biloba extract could slow progression from memory complaints to dementia in nearly 3,000 adults.
Clinical Trial
Mar 29, 2026 0
Heart Health
Merck's Niacin-Laropiprant Cholesterol Trial Terminated Before Completion
A phase 3 trial adding ERN/LRPT to statin therapy for dyslipidemia was terminated early, raising questions about the drug's clinical future.
Clinical Trial
May 26, 2026 0
Brain Health
Pimavanserin Shows Promise for Preventing Dementia Psychosis Relapse in Clinical Trial
Study tested whether pimavanserin could prevent return of hallucinations and delusions in dementia patients who initially responded to treatment.
Clinical Trial
Mar 29, 2026 0
Longevity & Aging
Bee Balm Extract Shows Promise for Slowing Biological Aging in Clinical Trial
Natural Monarda didyma supplement tested in 81-person study for anti-aging effects. Results could reshape longevity strategies.
Clinical Trial
Mar 28, 2026 0
Brain Health
Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
Clinical Trial
Mar 28, 2026 2
Brain Health
First Human Trial of Oral D-Peptide Drug Targeting Alzheimer's Toxic Oligomers Completed
Contraloid acetate, an oral all-D-peptide designed to disassemble toxic amyloid-beta oligomers, completed its first-in-human safety trial in 40 healthy volunteers.
Clinical Trial
Jun 12, 2026 0
Brain Health
Nordic Berries Put to the Test for Fighting Age-Related Cognitive Decline
A completed trial tests whether daily Nordic berry beverages can sharpen cognition in healthy adults over 12 weeks.
Clinical Trial
Jun 14, 2026 0
Page 1 of 2Next